Literature DB >> 23752063

Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.

Sang Yeop Lee1, Soo Jung Han, Sang Min Nam, Sang Chul Yoon, Ji Min Ahn, Tae-Im Kim, Eung Kweon Kim, Kyoung Yul Seo.   

Abstract

PURPOSE: To compare concentrations of tear cytokines in 3 groups composed of Sjögren syndrome (SS) dry eye, non-Sjögren syndrome (non-SS) dry eye, and normal subjects. Correlations between ocular surface parameters and tear cytokines were also investigated.
DESIGN: Prospective cross-sectional study.
METHODS: SS dry eye patients (n = 24; 40 eyes) were diagnosed with primary SS according to the criteria set by the American-European Consensus Group. Non-SS dry eye patients (n = 25; 40 eyes) and normal subjects (n = 21; 35 eyes) were also enrolled. Tear concentrations of interleukin (IL)-17, IL-6, IL-10, IL-4, IL-2, interferon γ (IFN-γ), and tumor necrosis factor α (TNF-α) were measured by a multiplex immunobead assay. Ocular Surface Disease Index (OSDI), tear film breakup time (TBUT), Schirmer I test, and fluorescein staining scores were obtained from dry eye patients.
RESULTS: All cytokine levels except for IL-2 were highest in the SS group, followed by non-SS dry eye group and control subjects. Concentrations of IL-17, TNF-α, and IL-6 were significantly different among the 3 groups (IL-17: SS > control P < .001, non-SS > control P = .042, SS > non-SS P < .001; TNF-α: SS > control P = .006, non-SS > control P = .034, SS > non-SS P = .029; IL-6: SS > control P = .002, non-SS > control P = .032, SS > non-SS P = .002). IL-17 was significantly correlated with TBUT (R = -0.22, P = .012) and Schirmer I test (R = -0.36, P = .027) scores in the SS group. IL-6 was significantly correlated only with TBUT (R = -0.38, P = .02) in the non-SS group.
CONCLUSIONS: Differences in tear cytokine levels and correlation patterns between SS dry eye and non-SS dry eye patients suggest the involvement of different inflammatory processes as causes of dry eye syndrome.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23752063     DOI: 10.1016/j.ajo.2013.04.003

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  70 in total

Review 1.  Autoimmunity in the pathogenesis and treatment of keratoconjunctivitis sicca.

Authors:  Katy C Liu; Kyle Huynh; Joseph Grubbs; Richard M Davis
Journal:  Curr Allergy Asthma Rep       Date:  2014-01       Impact factor: 4.806

Review 2.  TFOS DEWS II pain and sensation report.

Authors:  Carlos Belmonte; Jason J Nichols; Stephanie M Cox; James A Brock; Carolyn G Begley; David A Bereiter; Darlene A Dartt; Anat Galor; Pedram Hamrah; Jason J Ivanusic; Deborah S Jacobs; Nancy A McNamara; Mark I Rosenblatt; Fiona Stapleton; James S Wolffsohn
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 3.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  Quantitative assessment of oral mucosa and labial minor salivary glands in patients with Sjögren's syndrome using swept source OCT.

Authors:  Ireneusz Grulkowski; Jan K Nowak; Karol Karnowski; Paweł Zebryk; Mariusz Puszczewicz; Jaroslaw Walkowiak; Maciej Wojtkowski
Journal:  Biomed Opt Express       Date:  2013-12-16       Impact factor: 3.732

5.  IL-17, a potential therapeutic target for Sjögren's syndrome?

Authors:  Shan-Shan Liu; Ye Ding; Ji-Quan Lou
Journal:  Clin Rheumatol       Date:  2014-04-22       Impact factor: 2.980

6.  Comparison Between Viscous Teardrops and Saline Solution to Fill Orthokeratology Contact Lenses Before Overnight Wear.

Authors:  Gonzalo Carracedo; Cesar Villa-Collar; Alba Martin-Gil; Maria Serramito; Leticia Santamaría
Journal:  Eye Contact Lens       Date:  2018-09       Impact factor: 2.018

7.  The tear cytokine profile in patients with active Graves' orbitopathy.

Authors:  Morgan Yang; Yvonne Chung; Stephanie Lang; Nobuyo Yawata; Lay Leng Seah; Audrey Looi
Journal:  Endocrine       Date:  2017-11-16       Impact factor: 3.633

Review 8.  Corneal pain and experimental model development.

Authors:  Tina B McKay; Yashar Seyed-Razavi; Chiara E Ghezzi; Gabriela Dieckmann; Thomas J F Nieland; Dana M Cairns; Rachel E Pollard; Pedram Hamrah; David L Kaplan
Journal:  Prog Retin Eye Res       Date:  2018-11-16       Impact factor: 21.198

Review 9.  Current Approach to Dry Eye Disease.

Authors:  Valéria Valim; Virginia Fernandes Moça Trevisani; Jacqueline Martins de Sousa; Verônica Silva Vilela; Rubens Belfort
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

10.  Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction.

Authors:  Yu-Fei Gao; Rong-Jun Liu; Ya-Xin Li; Chenmilu Huang; Yi-Yun Liu; Chen-Xi Hu; Hong Qi
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.